(Q43275455)

English

Effect of EP4 agonist (ONO-4819CD) for patients with mild to moderate ulcerative colitis refractory to 5-aminosalicylates: a randomized phase II, placebo-controlled trial.

scientific article published in May 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19760781%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Effect of EP4 agonist (ONO-4819CD) for patients with mild to moderate ulcerative colitis refractory to 5-aminosalicylates: a randomized phase II, placebo-controlled trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19760781%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

Satoshi Teramukai

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19760781%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

10

object named as

Tsutomu Chiba

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19760781%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Hiroshi Nakase

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19760781%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Yoshihide Fujiyama

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19760781%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Nobuhide Oshitani

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19760781%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Toru Oga

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19760781%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Kimiko Nonomura

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19760781%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Toshiyuki Matsuoka

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19760781%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Yoshiyasu Esaki

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19760781%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Toshinori Murayama

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19760781%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Shuh Narumiya

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19760781%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19760781%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Inflammatory Bowel Diseases

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19760781%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19760781%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19760781%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

731-733

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19760781%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Expression of the EP4 prostaglandin E2 receptor subtype with rat dextran sodium sulphate colitis: colitis suppression by a selective agonist, ONO-AE1-329.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21080

21 January 2018

Prostaglandin E2 protects gastric mucosal cells from apoptosis via EP2 and EP4 receptor activation

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21080

21 January 2018

Inhibition of IL-6, TNF-alpha, and cyclooxygenase-2 protein expression by prostaglandin E2-induced IL-10 in bone marrow-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21080

21 January 2018

Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21080

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43275455&oldid=1721954140"